Sex as a Biological Variable Supplement - Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: Supplement to P03280
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$37,500Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Ali Mirazimi, Josef Penninger, Arthur Samuel Slutsky, Haibo Zhang…Research Location
CanadaLead Research Institution
Keenan Research Centre (Toronto, ON)Research Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified